Shareholder Information

Shares Issued

The number of shares in issue is 95,816,866.

Significant Shareholders


ShareholderNo. of ordinary shares% of issued share capital
Maven Income and Growth VCT110,611,86411.08%
Santi – 1990 SL10,386,18210.84%
Downing 1 VCT plc26,367,3186.65%
Chelverton Asset Management5,681,8185.93%
Octopus Investments 4,545,4554.74%
Equipos Medicos-Biologicos SA3,574,0003.73%
David Evans3,317,0003.46%
Sonia Rodriguez Clemente3,150,0003.29

held via Maven Income and Growth plc, Maven Income and Growth VCT 3 plc, Maven Income and Growth VCT 4 plc and Maven Income and Growth VCT 5 plc
2 held via Downing 1 VCT plc and Downing 4 VCT plc.

Director Shareholdings

DirectorNo. of ordinary shares% of issued share capital
Jordi Puig1,214,482,50015.11%
Matthew Walls10,762,50011.23%
Sergio Olivero23,574,0003.73%

1Aggregated with the interests of his wife, Sonia Rodriguez Clemente who holds 3,150,000 Ordinary Shares

2Jordi Puig and Sergio Olivero entered into an option agreement whereby Jordi Puig could call for the transfer of some or all of the Ordinary Shares in the capital of the Company held by Equipos Medico Biologicos S.A. Jordi Puig is therefore treated as being interested in such shares

* Paul Foulger’s wife, Laura Deegan, holds 568,182 shares in the Company representing 0.59% of the Company

Shares not in public hands

Insofar as it is aware, 62.05% of the Company's securities is not in public hands.

Statement of the Rights of Shareholders

The rights of shareholders are governed by UK law.

Restrictions in transfer of AIM securities

There are no restrictions on the transfer of the Company's ordinary shares.

UK City Code on Takeovers and Mergers

The Company is subject to the provisions of the City Code on Takeover and Mergers.

Other exchanges and trading platforms

GENinCode has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.

Shareholder Circulars

23 May 2022Notice of  Annual General Meeting held on 23 June 2022
 Form of Proxy for Annual General Meeting held on 23 June 2022
 Shareholder Letter regarding the Annual General Meeting held on 23 June 2022
 Results of Annual General Meeting held on 23 June 2022
Page last updated: 21 November 2022

Latest Share Price


Latest News

Financial Calendar

Interim Results 27 September 2022


Who Are We


Investor Alerts

GENinCode UK Limited
Oxford Science Park
John Eccles House
Robert Robinson Avenue
Oxford - UK
(+44) 186 5955 847
GENinCode S.L.U.
Rambla Egara, 235, ES- 08224
(+34) 936 690 321